Insights

Specialized Medical Research SOLTI's focus on cutting-edge clinical trials in breast cancer with novel targeted therapeutics presents an opportunity for partners providing advanced oncology research tools, innovative diagnostic technology, or personalized medicine solutions tailored for clinical settings.

Expanding Clinical Network With a robust network of over 80 leading hospital centers across Spain, Portugal, France, and Italy, SOLTI offers a strategic platform for healthcare technological solutions, digital health tools, and research management software to enhance multi-center trial coordination.

Innovation and Translational Research The emphasis on translational research and integrating innovative scientific approaches indicates potential for collaboration with biotech companies, laboratory service providers, and data analytics firms specializing in translational medicine and biomarker development.

Funding and Growth Potential Operating within a revenue range of 10 to 25 million dollars and actively conducting numerous ongoing trials, SOLTI may seek partnerships to expand its research capabilities, enhance clinical trial infrastructure, or develop new therapeutic agents through strategic collaborations.

Educational and Patient Engagement With extensive educational programs for medical professionals and patients, there are opportunities for companies offering digital education platforms, patient engagement tools, or communication solutions aimed at increasing participation and improving patient-centered care in clinical research.

SOLTI #cancerresearch Tech Stack

SOLTI #cancerresearch uses 8 technology products and services including Isotope, jQuery Migrate, Slider Revolution, and more. Explore SOLTI #cancerresearch's tech stack below.

  • Isotope
    Javascript Libraries
  • jQuery Migrate
    Javascript Libraries
  • Slider Revolution
    Miscellaneous
  • Elementor
    Page Builders
  • Google Tag Manager
    Tag Management
  • YouTube
    Video Players
  • mOxie
    Web & Portal Technology
  • Twitter
    Widgets

Media & News

SOLTI #cancerresearch's Email Address Formats

SOLTI #cancerresearch uses at least 1 format(s):
SOLTI #cancerresearch Email FormatsExamplePercentage
First.Last@gruposolti.orgJohn.Doe@gruposolti.org
40%
First.Middle@gruposolti.orgJohn.Michael@gruposolti.org
19%
FirLast@gruposolti.orgJohDoe@gruposolti.org
1%
First.Last@gruposolti.orgJohn.Doe@gruposolti.org
40%

Frequently Asked Questions

Where is SOLTI #cancerresearch's headquarters located?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's main headquarters is located at 89 Carrer de Balmes, 1º. The company has employees across 3 continents, including EuropeNorth AmericaAsia.

What is SOLTI #cancerresearch's stock symbol?

Minus sign iconPlus sign icon
SOLTI #cancerresearch is a publicly traded company; the company's stock symbol is N/A.

What is SOLTI #cancerresearch's official website and social media links?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's official website is gruposolti.org and has social profiles on LinkedIn.

What is SOLTI #cancerresearch's NAICS code?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's NAICS code is 5417 - Scientific Research and Development Services.

How many employees does SOLTI #cancerresearch have currently?

Minus sign iconPlus sign icon
As of December 2025, SOLTI #cancerresearch has approximately 129 employees across 3 continents, including EuropeNorth AmericaAsia. Key team members include Chief Executive Officer: R. E. N.Ceo: R. M. C.Cfo: M. P. V.. Explore SOLTI #cancerresearch's employee directory with LeadIQ.

What industry does SOLTI #cancerresearch belong to?

Minus sign iconPlus sign icon
SOLTI #cancerresearch operates in the Research Services industry.

What technology does SOLTI #cancerresearch use?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's tech stack includes IsotopejQuery MigrateSlider RevolutionElementorGoogle Tag ManagerYouTubemOxieTwitter.

What is SOLTI #cancerresearch's email format?

Minus sign iconPlus sign icon
SOLTI #cancerresearch's email format typically follows the pattern of First.Last@gruposolti.org. Find more SOLTI #cancerresearch email formats with LeadIQ.

When was SOLTI #cancerresearch founded?

Minus sign iconPlus sign icon
SOLTI #cancerresearch was founded in 1995.

SOLTI #cancerresearch

Research ServicesCatalonia, Spain51-200 Employees

SOLTI es un grupo referente en investigación clínica del cáncer en España. Con una trayectoria consolidada de 30 años, su actividad principal se centra en el diseño y ejecución de estudios clínicos de base traslacional dentro del ámbito académico. Su interés se ha focalizado en cáncer de mama, pero abre su ámbito a otros tumores. SOLTI tiene una experiencia acumulada de 80 ensayos clínicos y más de 30 en marcha y está integrado por 480 investigadores en una red de 100 centros entre España, Portugal e Irlanda, coordinados por una oficina central en la que trabaja un equipo de más de 60 personas. SOLTI forma parte de la Sociedad Española de Oncología Médica (SEOM) y es una asociación sin ánimo de lucro que, además de su actividad científica, cuenta con un programa de Educación Médica y para pacientes con múltiples iniciativas anuales. La misión de SOLTI es promover, desde una visión disruptiva, una investigación innovadora que mejore el bienestar y el pronóstico de los pacientes con cáncer.
SOLTI focuses its efforts on developing cutting-edge clinical trials with novel targeted therapeutics including innovative translational research, fostering the participation of research into breast cancer in international networks and promoting excellence in the management of breast cancer among their members. 


-----------------------------

SOLTI es un grupo académico dedicado a la investigación clínica en oncología que desarrolla ensayos clínicos de excelencia en cáncer de mama. Actualmente cuenta con más de 300 socios investigadores, así como una amplia red formada por más de 80 centros hospitalarios líderes en España, Portugal, Francia e Italia.

SOLTI centra sus esfuerzos en desarrollar ensayos clínicos de vanguardia con agentes contra diana, incorporar la investigación traslacional innovadora en todos los proyectos en los que participa y promover la excelencia en el tratamiento del cáncer de mama.

Section iconCompany Overview

Headquarters
89 Carrer de Balmes, 1º
Stock Symbol
N/A
NAICS Code
5417 - Scientific Research and Development Services
Founded
1995
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $10M$25M

    SOLTI #cancerresearch's revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    SOLTI #cancerresearch's revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.